← Back to Search

Light Therapy

LED application for Pain relief

N/A
Waitlist Available
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* 1) English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-op, 1, 2, 4, and 8 weeks
Awards & highlights

Summary

Study hypothesis: Low level laser (LED) will reduce initial bone resorption and improve primary stability of dental implant. It will also reduces post operative pain compared to patient without treatment Implant osseointegration depends on many factors including biocompatibility of implant materials, design, surface, surgical access, patient conditions, biomechanical status, and lack of primary stability. Several in vivo and in vitro studies showed the healing effect of low level laser therapy (LLLT) on bone by decreasing the initial bone resorption postoperatively and increasing the primary stability of the implant. It has also shown to have an analgesic effect intraorally when used post intraoral surgical procedures. The exact mechanism is unclear despite the fact that many hypothesis has been proposed. In our study, our goal is to present, in a randomized standardized clinical trial, the effect of LLLT on post operative implant stability assessed by resonance frequency analysis (RFA). We will assess the subjective measures of postoperative pain using visual analog scale (VAS).

Eligible Conditions
  • Implants
  • Pain relief

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-op, 1, 2, 4, and 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-op, 1, 2, 4, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Implant stability
Secondary study objectives
Post-op analgesics

Trial Design

2Treatment groups
Active Control
Group I: LED applicationActive Control1 Intervention
Patients in this group will be given the LED device and will be instructed on how and when to use it. They will receive LED treatment to the surgical site preoperatively by the surgeon for 20 minutes. Then, patients in this group will apply LED at home to the surgical site postoperatively at the day of surgery and for the following 9 postoperative days.
Group II: No LED applicationActive Control1 Intervention
These patients will receive conventional dental implant treatment without the application of the LED therapy.

Find a Location

Who is running the clinical trial?

Mount Sinai Hospital, CanadaLead Sponsor
200 Previous Clinical Trials
69,096 Total Patients Enrolled
Cameron Clokie, DDS, FRCSStudy DirectorUniversity of Toronto/Mount Sinai Hospital
~4 spots leftby Sep 2025